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Clonal variation in the arrest, survival and growth of
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MRC Clinical Oncology and Radiotherapeutics Unit, MRC Centre, Hills Road, Cambridge, CB2 2QH.
Summary The relationship between the long term retention of 125IUdR-labelled tumour cells in the lungs
and the formation of pulmonary lesions, has been examined for six in vitro isolated RIF-l clones. Following
i.v. injection, the initial number of cells trapped in the lungs was close to 100% in all cases. However, the
rates at which individual clones were subsequently cleared from the lungs and the fraction of persistently
retained cells varied considerably. Whilst clones also differed markedly in their lung colony formation
efficiency (L.C.F.E.) there was no clear correlation between the long term retention of tumour cells in the
lungs and subsequent metastasis formation, even when the retention of one clone was artifically increased in
the lungs by admixture with microspheres.
The fate after injection of clone 16 which is retained well in the lungs but which is of low L.C.F.E. has
been compared with that ofclone 19 which is retained poorly in the lung but which is of high L.C.F.E., using
in vitro clonogenic capacity as a measure of cell viability in the lungs. Our findings show that clone 16 cells
arrested in the lungs are in a viable, albeit "dormant", state some 26 days post i.v. injection. In contrast,
arrested clone 19 cells proliferate rapidly in the lungs. These data may indicate varying significance of tumour
cell and host properties in the metastatic success or failure ofindividual RIF-I clones.
The arrest of circulating tumour cells in the
microcirculation is an essential step in the
formation of blood-borne metastasis. The continued
survival of arrested cells depends on their abilities
subsequently to invade or extravasate through the
capillary endothelium, and establish a
microenvironment for vascularization and growth
(Fidler, 1978a; Fidler & Nicolson, 1978).
The importance of tumour cell properties in
determining cell arrest in the microcirculation is
suggested by the isolation of tumour cell lines that
show preferential organ metastasis (Nicolson et al.,
1978) and by studies showing that fusion of plasma
membrane vesicles from highly metastatic tumour
cells with poorly metastatic sublines can modify the
metastatic ability of the latter (Poste & Nicolson,
1980). Furthermore, organ specificity and
metastatic potential have been shown to correlate
with cell surface alterations (Shearman et al., 1980;
Rieber & Rieber, 1981). However, a number of
studies in experimental animal tumour systems have
shown that the formation and anatomical location
of metastases are also influenced by multiple host
factors and that these, together with properties
intrinsic to the tumour cells, dictate patterns of
metastatic spread (Proctor, 1976; Hart & Fidler,
1980; Poste & Fidler, 1980; Hart et al., 1981).
In the present study we investigate the interplay
between host and tumour cell properties by
examining the ability of individual clones, isolated
in vitro from the RIF-1 tumour (Twentyman et al.,
1980), to be arrested and retained in the lungs, their
ability to form pulmonary metastases and the
relationship between these two parameters.
Arrest and retention of cells by the lungs has
been monitored by measuring the loss of
radioactivity from the lung following i.v. injection
of 125IUdR labelled cells. Previous investigations
have established the efficacy of this isotope
technique for such studies (Fidler, 1970, 1978b;
Fidler et al., 1977; Liotta & DeLisa, 1977).
The in vivo survival and proliferative capacity of
selected RIF-1 clones in the lung post i.v. injection
has been assessed by an in vitro cell survival assay,
and pulmonary metastasis formation, by the lung
colony assay (Poste & Fidler, 1980). In addition the
retention of cells in the lungs has been artificially
manipulated by mixing cells with latex microspheres
in the lung colony assay since it has previously been
shown (Chambers et al., 1981) that lung colony
formation is significantly increased when cells are
injected in admixture with microspheres.
Materials and methods
Mice
Male mice of the inbred strain of C3H/Km, bred in
this unit, were used in all experiments. Within a
single experiment all mice were age-matched.
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Tumour
The RIF-1 tumour arose in the leg of a male
C3H/Km mouse following X-irradiation. The
tumour is non- or minimally-immunogenic in its
syngeneic host and grows either in vivo as a solid
tumour or in vitro as a monolayer, or as
multicellular tumour spheroids. By means of flow
cytometry and chromosome analysis the RIF- 1
tumour has been shown to contain both diploid
and tetraploid clonogenic subpopulations of
tumour cells (Twentyman et al., 1980).
Intramuscular RIF- 1 tumours were established
as previously described in the protocol for
maintenance and growth of the RIF- 1 tumour
(Twentyman et al., 1980). Thus tumours were
derived from cells which were no more than three
animal passages away from the primary tumour.
Culture conditions
The medium used throughout was Eagle's Minimal
Essential Medium with Earle's salts supplemented
with 20% new born calf serum (both Gibco Biocult
Ltd.) with antibiotics.
In vitro cloning
An i.m. RIF-1 tumour with an approximate volume
of 103mm3 was aseptically excised. The tumour
was minced finely and dissagregated in medium
containing bacterial neutral protease (type IX
Sigma London Chemical Company Ltd) at a
concentration of 1 mgml -I to yield a single cell
suspension as previously described (Reeve &
Twentyman, 1982). The suspension was centrifuged
at 200g for 5 min, the pellet resuspended in
medium and the resulting single cell suspension was
counted with the use of a haemocytometer. The cell
suspension was then diluted with medium to give a
final concentration of 2 cellsml- 1. One ml per well
of this was then plated into 24 well Linbro trays
(Flow Laboratories). Twenty-one days later, 10
clones were isolated from wells containing 1 colony
only. The clones were grown in vitro to confluence
in 25cm2 tissue culture flasks following which they
were disaggregated using medium containing
neutral protease (1 mgml-1) as previously described
(Reeve & Twentyman, 1982) and used for the
experimental purposes described below. Aliquots of
each clone were also preserved in liquid nitrogen
suspended in medium containing 10% dimethyl
sulphoxide.
Flow cytometry
Details of the flow cytometric technique used are
described elsewhere (Reeve & Twentyman, 1982).
Cells were stained with ethidium bromide solution
and analysed for DNA content/cell using the
Cambridge dual laser, multiparameter flow
cytometer. The ratio of the peak channel numbers
for the GI phase of the tumour cells to that of a
diploid standard (normal mouse bone marrow) was
determined and used for ploidy identification.
Cell volume analysis
Cell volume distribution analyses of cells with
differing ploidy values were carried out with a
model ZBI Coulter Counter. The system was
calibrated with latex beads. The average cell
diameter in a given sample was calculated from the
modal channel number of the volume distribution
of cells from confluent culture.
Quantitative analysis of tumour cell arrest and
retention in the lungs
To examine the arrest and retention kinetics of
RIF-1 clones in the lungs, viable cells growing in
exponential phase, monolayer culture were
incubated with 10ml medium containing
0.4pCiml-1 of [125I] 5-iodo-2-deoxyuridine
(125IUdR) (Amersham) (Brown & Parker, 1979) for
24h. The cell monolayer was then rinsed several
times with medium before being disaggregated and
a single cell suspension prepared for injection in
Hanks Balanced Salt Solution (HBSS). Mice were
killed at intervals between 5 min and 14 days
after injection of 105 cells. Three mice per group
were evaluated at each time point. Lungs were
collected from each mouse, washed in HBSS, fixed
in acetic alcohol for 24h and finally washed in
three changes of 95% ethyl alcohol to remove
ethanol soluble 125IUdR. The remaining ethanol-
insoluble radioactivity is associated with the DNA
of tumour cells present at the time of kill (Fidler,
1978b). After washing the lungs were blotted dry
and placed in a counting vial and counted for
125IUdR on a gamma-counter. Samples of the
injected cell suspension were also counted for total
125IUdR activity and the proportion of injected
activity recovered in the lungs at any given time
point was determined.
Quantitative lung colony assay
The metastatic ability of RIF-l clones was tested
by injecting 105 viable cells in a volume of 0.25ml
HBSS into the tail vein of each of 10 mice. The
mice were killed 26 days later, the lungs removed,
fixed in Bouin's solution and the number of lung
nodules counted.
In a modification of the above two assays 105
125IUdR-labelled cells of low lung colony
formation efficiency (LCFE) were mixed with 106
latex microspheres (15pm diamter; Uniscience Ltd.,HETEROGENEITY OF RIF-l TUMOUR CELLS 835
Cambridge) and injected into the tail veins of mice.
Animals were divided randomly into two groups
and used either for quantitative analysis of cell
arrest and retention in the lungs or for the lung
colony assay.
In vitro cell survival assay
To evaluate the survival and growth of selected
RIF-1 clones in the lungs post i.v. injection, 10o
cells were injected into the tail veins of mice as
described above. At time intervals ranging from
5min to 26 days the lungs were aseptically
removed, minced finely with scissors and
disaggregated in medium containing neutral
protease (1 mgml-1) for 2h on a magnetic stirrer.
The resulting suspension was filtered, centrifuged
and the pellet resuspended in medium. Serial
dilutions of the lung/tumour cell suspension were
prepared and aliquots of each were plated into petri
dishes containing lOml medium. After 13 days of
incubation at 37°C in an atmosphere of 95%
air+5% CO2 in a gassing incubator, the dishes
were stained with crystal violet and the number of
tumour colonies per set of lungs counted with the
aid of a dissecting microscope.
Growth ofRIF-J clones in i.m. site
Solid tumours, derived from selected RIF-1 clones,
were produced by inoculation of 105 cells in a
volume of 0.05ml HBSS i.m. at the base of the
gastrocnemius muscle of the leg. The volumes of leg
tumours were assessed at regular intervals by
measurement of two mutually perpendicular leg
diameters using a perspex gauge. Growth curves
were plotted for individual tumours and the time
taken for each tumour to reach a size whereby the
product of the leg diameters reached 100 mm2 was
determined.
Results
Arrest and retention ofRIF-I clones in the lungs
Figure la shows the arrest and retention kinetics
typically obtained for six 125IUdR labelled RIF-I
clones. Following injection the initial number of
cells trapped in the lungs was close to 100% in all
cases. However, the decay curves indicate that the
rates at which cells are subsequently lost from the
lungs either as a consequence of migration or
death, vary between the clones and result in
marked differences in the fraction of each clone
retained long term in the lungs. Thus clones 16, 20
and 26 were better retained in the lungs than clones
19, 5 and 28 (Figure la & b). The arrest and
retention kinetics of RIF-1 clones in the lungs was
repeated on three independent occasions. Although
absolute values for percent radioactivity remaining
in the lungs at various time points differed between
experiments the relationships between the clones
was similar within each experiment as shown in
Table I.
Table I Ratio of '25IUdR activity remaining in
lungs at day 14 for various clones relative to that
of clone 5
Clone number
5 19 28 20 26 16
Expt. I 1.0 1.1 0.75 2.3 2.1 3.8
Expt. II 1.0 1.7 1.5 4.7 4.2 6.8
Expt. III 1.0 1.5 0.81 2.4 2.5 4.2
Each ratio obtained is a comparison of mean
values derived from measurements of 3 mice. Data
were statistically analysed using Tukey's wholly
significant difference method (Tukey, 1953).
Retention of clones 16 and 26>clone 5 (P<0.005);
retention of clone 20>retention of clone 5
(0.1>P>0.05); retention of clones 28 and 19 was
not significantly different from that of clone 5.
Metastatic ability ofRIF-J clones
The diversity demonstrated in the metastatic ability
of the in vitro isolated RIF-1 clones (as measured
by the lung colony assay) is shown in Table II. A
wide range of metastatic ability was observed
amongst the clones ranging from a mean number of
lung colonies of 0.6 to >70. The uncloned in vitro
grown parent gave a mean of 57 lung colonies.
Table II shows that for the RIF-1 clones
examined, a good correlation exists between ploidy
and cell size. However, these data show that no
such relationship exists between these two
parameters and LCFE.
Figure 2 shows that there is no simple
relationship between the long term retention of cells
in the lungs and LCFE. For clones 5 and 28, poor
retention of these cells in the lungs is associated
with corresponding low LCFEs. Similarly, the
ability of clones 20 and 26 to be well retained in the
lungs is associated with increased LCFE. However,
the respective capacities of clones 16 and 19 to be
retained in the lungs do not predict for their
LCFEs.
Effect ofmicrospheres on the retention ofclone 16 in
the lungs and its ability to undergo metastasis
formation
Table III shows that the admixture of clone 16 cells836 J.G. REEVE & P.R. TWENTYMAN
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Figure la Lung arrest and retention kinetics of
'2IIUdR labelled RIF-l clones. 0 clone 16; 0 clone
19; * clone 28; E] clone 26; * clone 5; clone 20.
Each point represents a mean value derived from
measurements of 3 separate animals. The arrest and
retention kinetics of labelled RIF-I clones was
repeated on 3 independent occasions with similar data
to those shown above being obtained on each occasion
(see Table I).
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Figure lb Each point represents the % radioactivity
remaining in the lungs of an individual mouse within a
single experiment 14 days post i.v. injection of 105
labelled cells.
Table H Lung colony formation efficiences of REF-1 clones
Cell Lung colonies per set oflungs
diameter1 Expt I Expt II
Clone Ploidy (pm) Mean (s.e.) Median (range) Mean (s.e.) Median (range)
28 Diploid2 13.0 0.6 (0.3) 0 (0-2) 0.1 (0.1) 0 (0-1)
16 Tetraploid3 15.0 1.0 (0.4) 0.5 (0-4) 1.3 (1.0) 0 (0-7)
5 Tetraploid 14.5 2.6 (0.8) 3.0 (0-5) 1.5 (0.5) 1.0 (0-4)
21 Octoploid4 19.0 10.6 (2.6) 11.0 (1-21) 9.0 (2.7) 7.0 (1-21)
2 Diploid 13.0 11.0 (4.2) 6.0 (2-43) 11.1 (1.4) 10.0 (4-17)
23 Diploid 13.0 13.4 (2.8) 10.0 (5-25) 12.3 (1.9) 12.0 (4-21)
20 Tetraploid 16.0 32.2 (4.7) 29.0 (15-68) 26.0 (5.9) 33.0 (6-40)
26 Tetraploid 18.0 43.1 (13.8) 32.0 (8-124) 39.4 (5.8) 42.0 (15-60)
19 Tetraploid 14.5 70.1 (8.6) 74.0 (25-107) 64.7 (3.1) 78.0 (0-128)
PARENT Diploid+
RIF Tetraploid 59.7 (6.8) 64.0 (30-72) 54.1 (3.8) 56.0 (29-67)
'Based on a modal channel number of coulter volume using latex beads of different known diameter as
standards.
2Peak channel ratios of GI phase diploid tumour cells to GI phase normal mouse bone marrow being
in the range of 0.9-1.1:1
3Peak channel ratios of GI phase tetraploid tumour cells to Gl phase normal mouse bone marrow
being in the range of 1.8-2.2:1
4Peak channel ratios of Gl phase octoploid tumour cells to Gl phase normal mouse bone marrow
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Table 111 Effect of microspheres on the retention of clone 16 in the lungs and subsequent
LCFE
% cells present Lung colonies per set oflungs
at day 71 (s.e.) Mean2 (s.e.) Median (range)
105 clone 16 alone 0.29 (0.002) 1.0 (0.14) 1.0 (0-2)
105 clone 16+ 106 microspheres 1.5 (0.007) 16.0 (6.0) 13.0 (1-41)
105 clone 19 alone 0.11 (0.0009) 64.7 (13.1) 64.5 (20-105)
'Five mice per group
2Eight mice per group
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Figure 2 Relationship between tumour cell retention
in the lungs and L.C.F.E.. 0 clone 16; 0 clone 19; U
clone 28; a clone 26; * clone 5; > clone 20. For
lung colonies each point shows the mean+s.e. from 10
mice; for percent activity remaining in the lungs each
point represents a mean value derived from
measurements of 3 separate animals.
with latex microspheres substantially increased the
level at which these cells were retained by the lungs.
Similarly the LCFE of this clone was also enhanced
by the addition of microspheres to the inoculum.
However, the mean number of lung colonies
produced by clone 16 remained considerably less
than that produced by clone 19 in spite of the
much smaller number of clone 19 cells retained in
the lungs.
Survival andgrowth ofclones 16 and 19 in the lungs
Figure 3 shows the growth kinetics of clone 16 (of
low LCFE) and of clone 19 (of high LCFE) in the
lungs as determined by an in vitro cell survival
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Figure 3 Survival and growth of clones 16 and 19 in
the lungs. * clone 16; 0 clone 19. 2 mice per time
point. Each point represents the number of dish
colonies obtained from a single set oflungs.
assay. Number of dish colonies in vitro per set of
lungs has been used as a measure of the number of
viable tumour cells per set of lungs in vivo. Tumour
cell colonies were distinguished from the few
fibroblast colonies present, on the basis of
morphology, i.e. staining characteristics, lack of
contact inhibition. At time intervals between 1 and
4 days post i.v. injection, the number of viable
tumour cells present in the lungs of animals injected
with clone 16 was greater than that present in the
lungs of animals injected with clone 19 cells.
However, from day 4 there followed a sharp rise in
the number of viable clone 19 cells isolated from
the lungs, indicating the onset of proliferation by
this clone. Little increase in the number of cells
isolated from the lungs of animals injected with
clone 16 was evident until about day 26. Prior to
this time the number of clone 16 cells isolated from
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the lung remained relatively constant. This latter
finding confirms that the retained pulmonary
radioactivity observed with labelled clone 16 cells
did represent viable tumour cells. By Day 26 an
increase in the number of viable clone 16 in the
lungs was apparent but not in all animals. By 5
months post i.v. injection of clone 16 cells all but 2
out of 20 mice had died. At autopsy the lungs of
these animals were found to contain numerous
pulmonary lesions.
Growth ofRIF-I clones in the i.m. site
Table IV shows the times taken for tumours
derived from RIF-1 clones to reach a size such that
the product of the leg diameters lO mm2. There
is no significant difference between the in vivo
growth kinetics ofthe RIF-1 clones (P>0.1).
Table IV In vivo growth of i.m. tumours derived
from RIF-1 clones
Mean' time (days) taken
from cell inoculation to
lOOm2+2se2
Clone Expt I Expt II Expt III
5 19.7+1.2
16 19.4+0.8 16.2+ 1.32 16.5+ 1.22
19 16.1+ 1.0 17.6+ 1.52 16.5+0.96
20 20.6+1.4 16.1+3.0 19.3+2.26
26 16.6+1.0
28 19.4+1.8 17.0+1.34 20.1+1.48
'Eight mice per group.
2Data was analysed using 2 way analysis
classification of variance. P>0.1
Discussion
It is now well established that cells populating
experimental malignant tumours may differ
markedly in their metastatic abilities (for review,
see Poste & Fidler, 1980). Such differences may
reflect, in part, the intrinsic properties of the
tumour cells; the eventual outcome of metastasis,
however, depends on the complex interrelationships
of a number of host-tumour factors (Proctor, 1976;
Hart & Fidler, 1980; Poste & Fidler, 1980; Hart et
al., 1981).
Previous workers have investigated the
interaction between host and tumour cell during the
early stages of metastasis by examining the
relationship between the short term arrest and
clearance of labelled tumour cells in various organs
and subsequent metastasis formation (Fisher &
Fisher, 1967; Fidler, 1970; Fidler & Nicolson, 1976;
Fidler et al., 1977). These studies revealed that the
distribution. of overt metastases did not correlate
with initial capillary lodgement and that tumour
cell properties together with host immunity were
involved in determining initial cell arrest. The
present study has extended these investigations and
indicates the further involvement of tumour cell
properties and host factors after initial capillary
lodgement, in the determination of metastasis
formation.
For all RIF-1 clones tested the long term decay
of radioactivity in the lung, following i.v. injection
of 125IUdR labelled cells, exhibited the biphasic
nature shown to exist in a wide variety of tumour
host systems (Liotta & DeLisa, 1977).
The initial exponential decay over the first 40h
most likely reflects the loss (death or dislodgement)
of arrested cells from the pulmonary intravascular
space (Liotta & DeLisa, 1977). The second part of
the decay curves, in which cell clearance is much
reduced, may be due to tumour cells partially or
completely invading the interstitial space and thus
entering a compartment from which they are lost
less rapidly (Liotta & DeLisa, 1977). Thus the
observed differences in the decay curves produced
by the RIF-1 clones, most likely reflect the different
capacities of the RIF-1 clones to become arrested in
the lungs, to extravasate capillary endothelia and to
survive in the surrounding lung tissue. In contrast
to other findings (Suzuki et al., 1980), our
observations that both cell retention in the lung and
lung colonizing ability are independent of ploidy
and of cell size, indicates that mechanical factors
alone are not responsible for the metastatic ability
of individual RIF-1 clones.
Although cell retention in a given organ is an
essential step in the formation of blood-borne
metastases, the data presented here show that the
relationship between the long term retention of cells
by the lungs and subsequent pulmonary metastasis
formation is not a causal one for all RIF-1 clones.
Thus clone 16, of low LCFE, is well retained by the
lung whereas clone 19, of high LCFE, is retained
relatively poorly following i.v. injection. However,
for clones 5, 28, 20 and 26 a good correlation exists
between the fraction of cells persistently retained in
the lungs and subsequent metastasis formation.
These data suggest that different factors may
underlie the metastatic success or failure of the
various RIF-1 clones. Thus rapid loss of cells from
the lungs may explain the low LCFE of clones 5
and 28 but not that of clone 16. Similarly, an
ability to be well retained in the lung is not a
characteristic shared by all clones ofhigh LCFE.
These observations suggest that the phenotype of
the metastatic cell is not necessarily a uniform one
and that enhancement of one property may
compensate for a deficiency, but not loss, ofHETEROGENEITY OF RIF-1 TUMOUR CELLS 839
another. Thus the considerably greater proliferative
capacity of clone 19 in the lung site, as determined
by the in vitro survival assay, appears to
compensate for the poor ability of this clone to be
arrested in the lungs. However, the greater ability
of clone 16 to become arrested in the lungs is not
reflected by the LCFE of this clone. Thus although
admixture of microspheres with clone 16 cells
increased the cell arrest and retention of these cells
by a factor of 7 compared to that of clone 19 cells,
the number of lung colonies produced by clone 16
in the lung colony assay under these conditions
remained significantly less than that produced by
clone 19 cells.
The failure of clone 16 cells to form overt
pulmonary tumour nodules in the lung colony assay
is particularly interesting since the results obtained
from the in vitro cell survival assay show that cells
are arrested and retained by the lungs in a viable
state throughout this period. One possible
explanation for this finding is that tumour cell
division is matched by tumour cell death in the
lungs. This, however, is unlikely since the arrest
and retention kinetics of IUdR show that clone 16
cells do not continue to be lost from the lungs but
remain at an almost constant level from Day 4
onward. The most likely explanation for our
findings is that the proliferative capacity of clone 16
is considerably reduced in the lungs compared to,
for example, the i.m. site where this clone grows
rapidly as solid tumour.
The observation that the retention and survival
of a relative large number of clone 16 cells in the
lungs does not result in the formation of overt
pulmonary lesions for a considerabkeperiod of time
post i.v. injection is in agreement with similar
observations by Hart et al. (1981) and may be
analogous to the phenomenon of tumour dormancy
(Fisher & Fisher, 1959), as pulmonary metastases
are eventually detected in the lungs of animals
injected with clone 16 some 3-4 months post i.v.
injection. These results suggest that host organ
factors may significantly modulate the proliferative
capacity of clone 16 (but not that of clone 19) such
that the cells remain dormant in the lung until
triggered into growth by some factor or factors still
to be elucidated. We are currently attempting to
define the mechanisms involved in this
phenomenon.
Thus the present study, in addition to
characterizing subpopulations of RIF-I tumour
cells of high and low metastatic abilities, has
subclassified these into cells which differ in their
abilities to be retained and to proliferate in the
lung. Such a study has enabled an understanding of
why some cells are more, or less, metastatic (as
defined by LCFE) than others and has indicated
the varying significance of tumour cell and host
properties in the metastatic success or failure of
individual clones from a single "primary"
neoplasm. The data presented here indicates that
neither poorly nor highly metastatic RIF-I cells are
of a uniform phenotype, in terms of those
properties which are of importance in the
metastatic process, and reveal the subtlety and
complexity of the cellular heterogeneity underlying
the metastatic behaviour of the RIF-1 tumour.
We thank Mr. S. Chambers for running samples for flow
cytometry, Mr. L. Freedman for advice on methods of
statistical analysis and Ms. K.A. Wright for excellent
technical assistance.
References
BROWN, J.M. & PARKER, E.T. (1979). Host treatments
affecting artificial pulmonary metastases:
Interpretation of loss of radioactively labelled cells
from lungs, Br. J. Cancer, 40, 677.
CHAMBERS, A.F., HILL, R.P. & LING, V. (1981). Tumour
heterogeneity and stability of the metastatic phenotype
ofmouse KHT sarcoma cells. Cancer Res., 41, 1368.
FIDLER, I.J. (1970). Quantitative analysis of distribution
and fate of tumour emboli labelled with IUDR-125. J.
Natl Cancer Inst., 45, 775.
FIDLER, I.J. (1978a). The biology of cancer invasion and
metastasis. Adv. Cancer Res., 28, 149.
FIDLER, I.J. (1978b). General considerations for studies of
experimental metastasis. Methods Cancer Res., 15, 399.
FIDLER, I.J. & NICOLSON, G.L. (1976). Organ selectivity
for survival and growth of B16 melanoma variant
tumour lines. J. Natl Cancer Inst., 57, 1199.
FIDLER, I.J. & NICOLSON, G.L. (1978). The
immunobiology of experimental metastatic melanoma.
In: Basic Immunologic Mechanisms in Cancer. Ed.
Hanna, Jr. New York: Marcel Dekker, Inc.
FIDLER, I.J., GERSTEN, D.M. & RIGGS, C.W. (1977).
Relationship of host immune status to tumour cell
arrest, distribution, and survival in experimental
metastasis. Cancer, 40, 46.
FISHER, B. & FISHER, E.R. (1959). Experimental evidence
in support of the dormant tumour cell. Science, 130,
918.
FISHER, B. & FISHER, E.R. (1967). The organ distribution
of disseminated 5'Cr-labeled tumour cells. Cancer
Res., 27, 312.
HART, I. & FIDLER, I.J. (1980). Role of organ selectivity
in the determination of metastatic patterns of B16
melanoma. Cancer Res., 40, 2281.
HART, I., TALMADGE, J.E. & FIDLER, I.J. (1981).
Metastatic behaviour of a murine reticulum cell
sarcoma exhibiting organ specific growth. Cancer Res.,
41, 1281.840 J.G. REEVE & P.R. TWENTYMAN
LIOTTA, L. & DeLISA, C. (1977). Method for quantitating
tumour cell removal and tumour cell invasive capacity
in experimental metastasis. Cancer Res., 37, 4003.
NICOLSON, G.L., BRUNSON, K.W. & FIDLER, I.J. (1978).
Specificity of arrest, survival and growth of selected
metastatic variant cell lines. Cancer Res., 28, 4105.
POSTE, G. & FIDLER, I.J. (1980). The pathogenesis of
cancer metastasis. Nature, 283, 139.
POSTE, G. & NICOLSON, G.L. (1980). Arrest and
metastasis of blood-borne tumour cells are modified
by fusion of plasma membrane vesicles from highly
metastatic cells. Proc. Natl Acad. Sci. 77, 399.
PROCTOR, J.W. (1976). Rat sarcoma model supports both
"soil and seed" and "mechanical" theories of
metastatic spread. Br. J. Cancer, 34, 651.
REEVE, J.G. & TWENTYMAN, P.R. (1982). Ploidy
distribution of tumour cells derived from induced and
spontaneously arising metastases of a murine,
radiation induced sarcoma, RIF-1. Clin. Oncol., 18,
1001.
RIEBER, M. & RIEBER, M.S. (1981). Metastatic potential
correlates with cell surface protein alterations in B16
melanoma variants. Nature, 293, 74.
SHEARMAN, P.J., GALLATIN, W.M. & LONGNECKER,
B.M. (1980). Detection of a cell surface antigen
correlated with organ-specific metastasis. Nature, 286,
267.
SUZUKI, N., WILLIAMS, M., HUNTER, N.M. & WITHERS,
H.R. (1980). Malignant properties and DNA content of
daughter clones from a mouse fibrosarcoma:
Differentiation between malignant properties. Br. J.
Cancer, 42, 765.
TUKEY, J.W. (1953). The Problem of Multiple
Comparisons. Manuscript, Dept. Mathematics,
Princeton University.
TWENTYMAN, P.R., BROWN, J.M., GRAY, J.W., FRANKO,
A.J., SCOLES, M.A. & KALLMAN, R.F. (1980). A new
mouse tumour model system (RIF-1) for comparison
ofend-point studies. J. Natl Cancer Inst., 64, 595.